{
  "document": {
    "category": "csaf_security_advisory",
    "csaf_version": "2.0",
    "distribution": {
      "text": "Disclosure is not limited",
      "tlp": {
        "label": "WHITE",
        "url": "https://us-cert.cisa.gov/tlp/"
      }
    },
    "lang": "en-US",
    "notes": [
      {
        "category": "legal_disclaimer",
        "text": "All information products included in https://us-cert.cisa.gov/ics are provided \"as is\" for informational purposes only. The Department of Homeland Security (DHS) does not provide any warranties of any kind regarding any information contained within. DHS does not endorse any commercial product or service, referenced in this product or otherwise. Further dissemination of this product is governed by the Traffic Light Protocol (TLP) marking in the header. For more information about TLP, see https://us-cert.cisa.gov/tlp/.",
        "title": "Legal Notice"
      },
      {
        "category": "general",
        "text": "This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov",
        "title": "CISA Disclaimer"
      },
      {
        "category": "general",
        "text": "CISA recommends users take defensive measures to minimize the risk of exploitation.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "Minimize network exposure for all control system devices and/or systems, ensuring they are not accessible from the internet.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "Locate control system networks and remote devices behind firewalls and isolating them from business networks.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "When remote access is required, use more secure methods, such as Virtual Private Networks (VPNs). Recognize VPNs may have vulnerabilities, should be updated to the most recent version available, and are only as secure as the connected devices.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "CISA also provides a section for control systems security recommended practices on the ICS webpage on cisa.gov. Several CISA products detailing cyber defense best practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "CISA encourages organizations to implement recommended cybersecurity strategies for proactive defense of ICS assets.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "Additional mitigation guidance and recommended practices are publicly available on the ICS webpage at cisa.gov in the technical information paper, ICS-TIP-12-146-01B--Targeted Cyber Intrusion Detection and Mitigation Strategies.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "Organizations observing suspected malicious activity should follow established internal procedures and report findings to CISA for tracking and correlation against other incidents.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "CISA also recommends users take the following measures to protect themselves from social engineering attacks: Do not click web links or open attachments in unsolicited email messages. Refer to Recognizing and Avoiding Email Scams for more information on avoiding email scams. Refer to Avoiding Social Engineering and Phishing Attacks for more information on social engineering attacks.",
        "title": "Recommended Practices"
      }
    ],
    "publisher": {
      "category": "coordinator",
      "contact_details": "central@cisa.dhs.gov",
      "name": "CISA",
      "namespace": "https://www.cisa.gov/"
    },
    "references": [
      {
        "category": "self",
        "summary": "ICS Advisory ICSA-15-125-01B JSON",
        "url": "https://raw.githubusercontent.com/cisagov/CSAF/develop/csaf_files/OT/white/2015/icsa-15-125-01b.json"
      },
      {
        "category": "self",
        "summary": "ICS Advisory ICSA-15-125-01B - Web Version",
        "url": "https://www.cisa.gov/news-events/ics-advisories/icsa-15-125-01b"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/uscert/ics/alerts/ICS-ALERT-10-301-01"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/resources-tools/resources/ics-recommended-practices"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/topics/industrial-control-systems"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://us-cert.cisa.gov/sites/default/files/recommended_practices/NCCIC_ICS-CERT_Defense_in_Depth_2016_S508C.pdf"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/sites/default/files/publications/Cybersecurity_Best_Practices_for_Industrial_Control_Systems.pdf"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/uscert/ics/tips/ICS-TIP-12-146-01B"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/uscert/sites/default/files/publications/emailscams0905.pdf"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/uscert/ncas/tips/ST04-014"
      }
    ],
    "title": "Hospira LifeCare PCA Infusion System Vulnerabilities",
    "tracking": {
      "current_release_date": "2025-06-06T16:07:30.609417Z",
      "generator": {
        "date": "2025-06-06T16:07:30.609353Z",
        "engine": {
          "name": "CISA CSAF Generator",
          "version": "1.0.0"
        }
      },
      "id": "ICSA-15-125-01B",
      "initial_release_date": "2015-02-05T07:00:00.000000Z",
      "revision_history": [
        {
          "date": "2015-02-05T07:00:00.000000Z",
          "legacy_version": "Initial",
          "number": "1",
          "summary": "Initial Publication"
        },
        {
          "date": "2025-06-06T16:07:30.609417Z",
          "legacy_version": "CSAF Conversion",
          "number": "2",
          "summary": "Advisory converted into a CSAF"
        }
      ],
      "status": "final",
      "version": "2"
    }
  },
  "product_tree": {
    "branches": [
      {
        "branches": [
          {
            "branches": [
              {
                "category": "product_version_range",
                "name": "<=5.0",
                "product": {
                  "name": "Hospira LifeCare PCA Infusion System: <=5.0",
                  "product_id": "CSAFPID-0001"
                }
              }
            ],
            "category": "product_name",
            "name": "LifeCare PCA Infusion System"
          }
        ],
        "category": "vendor",
        "name": "Hospira"
      }
    ]
  },
  "vulnerabilities": [
    {
      "cve": "CVE-2014-5406",
      "cwe": {
        "id": "CWE-345",
        "name": "Insufficient Verification of Data Authenticity"
      },
      "notes": [
        {
          "category": "summary",
          "text": "The Hospira LifeCare PCA Infusion System before 7.0 does not validate network traffic associated with sending a (1) drug library, (2) software update, or (3) configuration change, which allows remote attackers to modify settings or medication data via packets on the (a) TELNET, (b) HTTP, (c) HTTPS, or (d) UPNP port.  NOTE: this issue might overlap CVE-2015-3459.",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001"
        ]
      },
      "remediations": [
        {
          "category": "mitigation",
          "details": "ICS-CERT has been working with Hospira since May 2014 to address the vulnerabilities in the LifeCare PCA Infusion System. Hospira has developed a new version of the PCS Infusion System, Version 7.0 that addresses the identified vulnerabilities. According to Hospira, Version 7.0 has Port 20/FTP and Port 23/TELNET closed by default to prevent unauthorized access.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "Hospira has developed a new version of the LifeCare PCA Infusion System and has stated that this new version will mitigate these vulnerabilities. Specifically, the new version is intended to: Mitigate unauthorized remote access to the device,Disable the ability for unauthorized changes to the medication library, Remove hard-coded passwords to gain access to the device, Encrypt storage of wireless network keys, and Ensure that the vulnerable versions of AppWeb are no longer used.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "Existing PCA Infusion Systems running Version 5.0 can be upgraded to Version 7.0 when it becomes available. Hospira will be retiring older versions of the LifeCare PCA Infusion System, Versions 2 and Versions 3, by the end of the year, 2015.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "Hospira’s premarket 510(k) submission for the new LifeCare PCA Infusion System (Version 7.0) is currently being reviewed by the FDA. The release of the new system will be dependent on the clearance of Hospira’s 510(k).",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "For additional information about Hospira’s upcoming release, contact Hospira’s technical support at 1-800-241-4002.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        }
      ],
      "scores": [
        {
          "cvss_v2": {
            "baseScore": 7.6,
            "vectorString": "AV:N/AC:H/Au:N/C:C/I:C/A:C",
            "version": "2.0"
          },
          "products": [
            "CSAFPID-0001"
          ]
        }
      ]
    },
    {
      "cve": "CVE-2015-1011",
      "cwe": {
        "id": "CWE-259",
        "name": "Use of Hard-coded Password"
      },
      "notes": [
        {
          "category": "summary",
          "text": "Hospira LifeCare PCA Infusion System before 7.0 has hardcoded credentials, which makes it easier for remote attackers to obtain access via unspecified vectors.",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001"
        ]
      },
      "remediations": [
        {
          "category": "mitigation",
          "details": "ICS-CERT has been working with Hospira since May 2014 to address the vulnerabilities in the LifeCare PCA Infusion System. Hospira has developed a new version of the PCS Infusion System, Version 7.0 that addresses the identified vulnerabilities. According to Hospira, Version 7.0 has Port 20/FTP and Port 23/TELNET closed by default to prevent unauthorized access.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "Hospira has developed a new version of the LifeCare PCA Infusion System and has stated that this new version will mitigate these vulnerabilities. Specifically, the new version is intended to: Mitigate unauthorized remote access to the device,Disable the ability for unauthorized changes to the medication library, Remove hard-coded passwords to gain access to the device, Encrypt storage of wireless network keys, and Ensure that the vulnerable versions of AppWeb are no longer used.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "Existing PCA Infusion Systems running Version 5.0 can be upgraded to Version 7.0 when it becomes available. Hospira will be retiring older versions of the LifeCare PCA Infusion System, Versions 2 and Versions 3, by the end of the year, 2015.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "Hospira’s premarket 510(k) submission for the new LifeCare PCA Infusion System (Version 7.0) is currently being reviewed by the FDA. The release of the new system will be dependent on the clearance of Hospira’s 510(k).",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "For additional information about Hospira’s upcoming release, contact Hospira’s technical support at 1-800-241-4002.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        }
      ],
      "scores": [
        {
          "cvss_v2": {
            "baseScore": 10.0,
            "vectorString": "AV:N/AC:L/Au:N/C:C/I:C/A:C",
            "version": "2.0"
          },
          "products": [
            "CSAFPID-0001"
          ]
        }
      ]
    },
    {
      "cve": "CVE-2015-1012",
      "cwe": {
        "id": "CWE-312",
        "name": "Cleartext Storage of Sensitive Information"
      },
      "notes": [
        {
          "category": "summary",
          "text": "Wireless keys are stored in plain text on version 5 of the Hospira LifeCare PCA Infusion System. According to Hospira, version 3 of the LifeCare PCA Infusion System is not indicated for wireless use, is not shipped with wireless capabilities, and should not be modified to be used in a wireless capacity in a clinical setting. Hospira has developed a new version of the PCS Infusion System, version 7.0 that addresses the identified vulnerabilities. Version 7.0 has Port 20/FTP and Port 23/TELNET closed by default to prevent unauthorized access.",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001"
        ]
      },
      "remediations": [
        {
          "category": "mitigation",
          "details": "ICS-CERT has been working with Hospira since May 2014 to address the vulnerabilities in the LifeCare PCA Infusion System. Hospira has developed a new version of the PCS Infusion System, Version 7.0 that addresses the identified vulnerabilities. According to Hospira, Version 7.0 has Port 20/FTP and Port 23/TELNET closed by default to prevent unauthorized access.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "Hospira has developed a new version of the LifeCare PCA Infusion System and has stated that this new version will mitigate these vulnerabilities. Specifically, the new version is intended to: Mitigate unauthorized remote access to the device,Disable the ability for unauthorized changes to the medication library, Remove hard-coded passwords to gain access to the device, Encrypt storage of wireless network keys, and Ensure that the vulnerable versions of AppWeb are no longer used.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "Existing PCA Infusion Systems running Version 5.0 can be upgraded to Version 7.0 when it becomes available. Hospira will be retiring older versions of the LifeCare PCA Infusion System, Versions 2 and Versions 3, by the end of the year, 2015.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "Hospira’s premarket 510(k) submission for the new LifeCare PCA Infusion System (Version 7.0) is currently being reviewed by the FDA. The release of the new system will be dependent on the clearance of Hospira’s 510(k).",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "For additional information about Hospira’s upcoming release, contact Hospira’s technical support at 1-800-241-4002.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        }
      ],
      "scores": [
        {
          "cvss_v2": {
            "baseScore": 6.4,
            "vectorString": "AV:N/AC:L/Au:N/C:P/I:P/A:N",
            "version": "2.0"
          },
          "products": [
            "CSAFPID-0001"
          ]
        }
      ]
    },
    {
      "cve": "CVE-2015-3459",
      "cwe": {
        "id": "CWE-285",
        "name": "Improper Authorization"
      },
      "notes": [
        {
          "category": "summary",
          "text": "The communication module on the Hospira LifeCare PCA Infusion System before 7.0 does not require authentication for root TELNET sessions, which allows remote attackers to modify the pump configuration via unspecified commands.",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001"
        ]
      },
      "remediations": [
        {
          "category": "mitigation",
          "details": "ICS-CERT has been working with Hospira since May 2014 to address the vulnerabilities in the LifeCare PCA Infusion System. Hospira has developed a new version of the PCS Infusion System, Version 7.0 that addresses the identified vulnerabilities. According to Hospira, Version 7.0 has Port 20/FTP and Port 23/TELNET closed by default to prevent unauthorized access.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "Hospira has developed a new version of the LifeCare PCA Infusion System and has stated that this new version will mitigate these vulnerabilities. Specifically, the new version is intended to: Mitigate unauthorized remote access to the device,Disable the ability for unauthorized changes to the medication library, Remove hard-coded passwords to gain access to the device, Encrypt storage of wireless network keys, and Ensure that the vulnerable versions of AppWeb are no longer used.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "Existing PCA Infusion Systems running Version 5.0 can be upgraded to Version 7.0 when it becomes available. Hospira will be retiring older versions of the LifeCare PCA Infusion System, Versions 2 and Versions 3, by the end of the year, 2015.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "Hospira’s premarket 510(k) submission for the new LifeCare PCA Infusion System (Version 7.0) is currently being reviewed by the FDA. The release of the new system will be dependent on the clearance of Hospira’s 510(k).",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "For additional information about Hospira’s upcoming release, contact Hospira’s technical support at 1-800-241-4002.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        }
      ],
      "scores": [
        {
          "cvss_v2": {
            "baseScore": 10.0,
            "vectorString": "AV:N/AC:L/Au:N/C:C/I:C/A:C",
            "version": "2.0"
          },
          "products": [
            "CSAFPID-0001"
          ]
        }
      ]
    },
    {
      "cve": "CVE-2015-3955",
      "cwe": {
        "id": "CWE-121",
        "name": "Stack-based Buffer Overflow"
      },
      "notes": [
        {
          "category": "summary",
          "text": "Stack-based buffer overflow in Hospira LifeCare PCA Infusion System 5.0 and earlier, and possibly other versions, allows remote attackers to execute arbitrary code via unspecified vectors.",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001"
        ]
      },
      "remediations": [
        {
          "category": "mitigation",
          "details": "ICS-CERT has been working with Hospira since May 2014 to address the vulnerabilities in the LifeCare PCA Infusion System. Hospira has developed a new version of the PCS Infusion System, Version 7.0 that addresses the identified vulnerabilities. According to Hospira, Version 7.0 has Port 20/FTP and Port 23/TELNET closed by default to prevent unauthorized access.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "Hospira has developed a new version of the LifeCare PCA Infusion System and has stated that this new version will mitigate these vulnerabilities. Specifically, the new version is intended to: Mitigate unauthorized remote access to the device,Disable the ability for unauthorized changes to the medication library, Remove hard-coded passwords to gain access to the device, Encrypt storage of wireless network keys, and Ensure that the vulnerable versions of AppWeb are no longer used.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "Existing PCA Infusion Systems running Version 5.0 can be upgraded to Version 7.0 when it becomes available. Hospira will be retiring older versions of the LifeCare PCA Infusion System, Versions 2 and Versions 3, by the end of the year, 2015.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "Hospira’s premarket 510(k) submission for the new LifeCare PCA Infusion System (Version 7.0) is currently being reviewed by the FDA. The release of the new system will be dependent on the clearance of Hospira’s 510(k).",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "For additional information about Hospira’s upcoming release, contact Hospira’s technical support at 1-800-241-4002.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        }
      ],
      "scores": [
        {
          "cvss_v2": {
            "baseScore": 7.6,
            "vectorString": "AV:N/AC:H/Au:N/C:C/I:C/A:C",
            "version": "2.0"
          },
          "products": [
            "CSAFPID-0001"
          ]
        }
      ]
    },
    {
      "cve": "CVE-2015-3957",
      "cwe": {
        "id": "CWE-321",
        "name": "Use of Hard-coded Cryptographic Key"
      },
      "notes": [
        {
          "category": "summary",
          "text": "Hospira LifeCare PCA Infusion System before 7.0 stores private keys and certificates, which has unspecified impact and attack vectors.",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001"
        ]
      },
      "remediations": [
        {
          "category": "mitigation",
          "details": "ICS-CERT has been working with Hospira since May 2014 to address the vulnerabilities in the LifeCare PCA Infusion System. Hospira has developed a new version of the PCS Infusion System, Version 7.0 that addresses the identified vulnerabilities. According to Hospira, Version 7.0 has Port 20/FTP and Port 23/TELNET closed by default to prevent unauthorized access.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "Hospira has developed a new version of the LifeCare PCA Infusion System and has stated that this new version will mitigate these vulnerabilities. Specifically, the new version is intended to: Mitigate unauthorized remote access to the device,Disable the ability for unauthorized changes to the medication library, Remove hard-coded passwords to gain access to the device, Encrypt storage of wireless network keys, and Ensure that the vulnerable versions of AppWeb are no longer used.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "Existing PCA Infusion Systems running Version 5.0 can be upgraded to Version 7.0 when it becomes available. Hospira will be retiring older versions of the LifeCare PCA Infusion System, Versions 2 and Versions 3, by the end of the year, 2015.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "Hospira’s premarket 510(k) submission for the new LifeCare PCA Infusion System (Version 7.0) is currently being reviewed by the FDA. The release of the new system will be dependent on the clearance of Hospira’s 510(k).",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "For additional information about Hospira’s upcoming release, contact Hospira’s technical support at 1-800-241-4002.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        }
      ],
      "scores": [
        {
          "cvss_v2": {
            "baseScore": 4.6,
            "vectorString": "AV:L/AC:L/Au:N/C:P/I:P/A:P",
            "version": "2.0"
          },
          "products": [
            "CSAFPID-0001"
          ]
        }
      ]
    },
    {
      "cve": "CVE-2015-3958",
      "cwe": {
        "id": "CWE-400",
        "name": "Uncontrolled Resource Consumption"
      },
      "notes": [
        {
          "category": "summary",
          "text": "Hospira LifeCare PCA Infusion System 5.0 and earlier, and possibly other versions, allows remote attackers to cause a denial of service (forced manual reboot) via a flood of TCP packets.",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001"
        ]
      },
      "remediations": [
        {
          "category": "mitigation",
          "details": "ICS-CERT has been working with Hospira since May 2014 to address the vulnerabilities in the LifeCare PCA Infusion System. Hospira has developed a new version of the PCS Infusion System, Version 7.0 that addresses the identified vulnerabilities. According to Hospira, Version 7.0 has Port 20/FTP and Port 23/TELNET closed by default to prevent unauthorized access.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "Hospira has developed a new version of the LifeCare PCA Infusion System and has stated that this new version will mitigate these vulnerabilities. Specifically, the new version is intended to: Mitigate unauthorized remote access to the device,Disable the ability for unauthorized changes to the medication library, Remove hard-coded passwords to gain access to the device, Encrypt storage of wireless network keys, and Ensure that the vulnerable versions of AppWeb are no longer used.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "Existing PCA Infusion Systems running Version 5.0 can be upgraded to Version 7.0 when it becomes available. Hospira will be retiring older versions of the LifeCare PCA Infusion System, Versions 2 and Versions 3, by the end of the year, 2015.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "Hospira’s premarket 510(k) submission for the new LifeCare PCA Infusion System (Version 7.0) is currently being reviewed by the FDA. The release of the new system will be dependent on the clearance of Hospira’s 510(k).",
          "product_ids": [
            "CSAFPID-0001"
          ]
        },
        {
          "category": "mitigation",
          "details": "For additional information about Hospira’s upcoming release, contact Hospira’s technical support at 1-800-241-4002.",
          "product_ids": [
            "CSAFPID-0001"
          ]
        }
      ],
      "scores": [
        {
          "cvss_v2": {
            "baseScore": 7.8,
            "vectorString": "AV:N/AC:L/Au:N/C:N/I:N/A:C",
            "version": "2.0"
          },
          "products": [
            "CSAFPID-0001"
          ]
        }
      ]
    }
  ]
}